CoreTissue BioEngineering
PrivateLast Round
Grant
Jan 9, 2026
Total Funding Raised
$11.36M
Company Overview
CoreTissue BioEngineering is a bioengineering company that develops, manufactures, and sells medical devices using proprietary decellularization technology for anterior cruciate ligament reconstruction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoreTissue BioEngineering Comparables
Compare CoreTissue BioEngineering with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Miach Orthopaedics | 79% | |
| Arthrex | 65% | |
| Johnson & Johnson | 64% | |
CoreTissue BioEngineering Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 9, 2026 | ||||
| Series A Extension | Nov 10, 2025 | ||||
| Accelerator | Jul 29, 2024 | ||||
| Series A | Jan 1, 2023 |
CoreTissue BioEngineering Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Energy and Industrial Technology Development Organization | Grant |
| WERU Investment Co. | Series A Extension |
| Japan Science and Technology Agency | Series A |
| Mitsui Sumitomo Insurance Capital Co., Ltd. | Series A Extension |
| Fogarty Innovation | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2023
$4.3M round with participation from AXA and JST.
CoreTissue BioEngineering Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CoreTissue BioEngineering's valuation, stock price, and market status.